Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

AUSTRAL PHARMA : revenue, balance sheet and financial ratios

AUSTRAL PHARMA is a French company founded 5 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in SAINT-PAUL (97435), this company of category PME shows in 2024 a net income positive of 417 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - AUSTRAL PHARMA (SIREN 885136689)
Indicator 2024 2023 2022 2021
Revenue N/C N/C N/C N/C
Net income 417 140 € 228 350 € 452 198 € 422 319 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

En 2024, AUSTRAL PHARMA genera un resultado neto positivo de 417 k€. Evolución 2021-2024: 422 k€ -> 417 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

417 140 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 0%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 88%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.172%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

88.099%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

65.2%

Solvency indicators evolution
AUSTRAL PHARMA

Sector positioning

Ratio de endeudamiento
0.17 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Bueno

En 2024, el ratio de endeudamiento de AUSTRAL PHARMA (0.17) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.

Autonomía financiera
88.1% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excelente +15 pts over 3 years

En 2024, el autonomía financiera de AUSTRAL PHARMA (88.1%) se sitúa en el top 25% del sector. Este ratio representa la parte del patrimonio en la financiación total. Alta autonomía refleja independencia financiera y capacidad para absorber choques.

Liquidity ratios

El ratio de liquidez se sitúa en 725.63. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

725.632

Liquidity indicators evolution
AUSTRAL PHARMA

Sector positioning

Ratio de liquidez
725.63 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excelente

En 2024, el ratio de liquidez de AUSTRAL PHARMA (725.63) se sitúa en el top 25% del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio superior a 1 asegura cobertura cómoda de vencimientos a corto plazo.

Positioning of AUSTRAL PHARMA in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of AUSTRAL PHARMA is estimated at 342 687 € (range 130 429€ - 1 251 449€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
130k€ 342k€ 1251k€
342 687 € Range: 130 429€ - 1 251 449€
NAF 5 all-time

Valuation method used

Net Income Multiple
417 140 € × 0.8x = 342 687 €
Range: 130 429€ - 1 251 450€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare AUSTRAL PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about AUSTRAL PHARMA

What is the revenue of AUSTRAL PHARMA ?

The revenue of AUSTRAL PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is AUSTRAL PHARMA profitable?

Yes, AUSTRAL PHARMA generated a net profit of 417 k€ in 2024.

Where is the headquarters of AUSTRAL PHARMA ?

The headquarters of AUSTRAL PHARMA is located in SAINT-PAUL (97435), in the department La Reunion.

Where to find the tax return of AUSTRAL PHARMA ?

The tax return of AUSTRAL PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does AUSTRAL PHARMA operate?

AUSTRAL PHARMA operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.